Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Rotasiil (BRV-PV) Lot Consistency and Interference
NCT02584816Phase 3Completed
- Sponsor
- Serum Institute of India
- Start
- Nov 2015
- Primary completion
- Apr 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Rotasil in rotavirus gastroenteritis, sponsored by Serum Institute of India. Started Nov 2015; status: completed.
02
Drugs
Rotasil
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT02584816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584816.